Biotech Values

[DewDiligence]

ABT—In light of #msg-74608528, I will not be surprised if only ABT-333 [i.e. not ABT-072] is moved to phase III.

That’s a safe assumption, IMO; according to clinicaltrials.gov, there are zero ABT-072 studies in progress or planned:

http://www.clinicaltrials.gov/ct2/results?flds=Xs&flds=a&flds=b&flds=c&flds=f&flds=g&flds=n&term=abt-072&show_flds=Y